Delivery Order SPE2DB22D3501-SPE2DB24FUK52
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $26,116.35 for the supply of 4,562,252 units of NITROFURANTOIN MONO-MCR 100 MG. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 21, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of Nitrofurantoin 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract, valued at $24,662.14, is a delivery order with a firm fixed price. It does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml Suspension, a pharmaceutical product, with a ceiling value of $18,234.82. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,331.51 Firm Fixed Price Delivery Order is for the supply of 240 mL bottles of Nitrofurantoin 25 mg/5 mL oral suspension, a medication used to treat urinary tract infections. The contract has an ultimate completion date of August 11, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract has a ceiling value of $11,218.40 and runs through December 1, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,240.97 Firm Fixed Price Delivery Order contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of January 5, 2024 and was awarded on January 4, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,909.95 for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order valued at $12,442.59 for the supply of Nitrofurantoin 25 mg/5 ml suspension, a pharmaceutical product used to treat urinary tract infections. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a substantial Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $9,092.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, and is structured as a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of February 1, 2024 and was awarded on January 31, 2024. This award is not...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,960,849 units of the pharmaceutical product Nitrofurantoin Mono-MCR 100 MG. The $1,531.01 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUK52Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The award, valued at $5,183.25, is a delivery order contract with a firm fixed price. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 1, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 1/31/24 |